Search result for 'eribulin mesylate injection'

Glenmark Pharmaceuticals launches generic Eribulin Mesylate Injection in the US, a cancer treatment drug. Aims to provide affordable alternatives.

Gland Pharma receives USFDA approval for Eribulin Mesylate Injection, a generic breast cancer drug, expected to be the first in the market. The company plans to launch the product soon.